Some of the compounds presented are investigational or are being investigated for uses that have not been approved by the US Food and Drug Administration (FDA), European Medicines Agency (EMA), or other health authorities.
Scientific Congress Publications
Supported by Bayer Pharmaceuticals
ISC 2026
Characteristics and Outcomes of the Real-World Cohort of Patients With Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack Compatible With the OCEANIC-STROKE Clinical Trial Population in Japan
Date/Time:
Thursday, February 5, 2026 / 12:30 PM – 2:30 PM, CST
Presenting Author:
Teruyuki Hirano
Poster Session:
Moderated Digital Oral Abstracts